
Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

